Septerna Quarterly Cash Flow Statement
NASDAQ: SEPNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
38.37+1.47 (+3.98%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Septerna free cash flow
In the quarter ended Jun 30, 2026, Septerna generated -$22.2 million of operating cash flow and spent $0 on capital expenditures. That left free cash flow of -$22.2 million, a free-cash-flow margin of -82.9% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Septerna cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -13.03M | -8.64M | -10.74M | 8.17M | -24.84M | -21.48M | -20.67M | -20.52M | -16.44M | -14.17M | 34.89M | -10.95M |
| Net Income growth (YoY) | — | — | — | — | — | — | -159.23% | — | — | — | — | — |
| Depreciation & Amortization | 400.00K | 400.00K | 400.00K | 400.00K | 400.00K | 400.00K | 400.00K | 400.00K | 300.00K | 300.00K | 200.00K | 200.00K |
| Stock-Based Compensation | 5.07M | 6.01M | 2.66M | 2.53M | 1.81M | 1.48M | 1.26M | 683.00K | 628.00K | 577.00K | 575.00K | 347.00K |
| Change in Working Capital | -16.82M | -18.98M | -10.02M | -11.55M | 2.27M | 1.10M | -1.65M | 2.56M | 29.00K | -407.00K | 740.00K | — |
| Operating Cash Flow | -22.18M | -25.63M | -14.99M | 168.81M | -20.29M | -23.34M | -20.96M | -16.81M | -12.99M | -16.71M | -8.80M | — |
| Capital Expenditures | 0 | -832.00K | -65.00K | -13.00K | -58.00K | -382.00K | -612.00K | -578.00K | -149.00K | -764.00K | -1.24M | — |
| Investing Cash Flow | 18.41M | -23.82M | -185.30M | -38.39M | -786.00K | -4.87M | -133.24M | -24.79M | -12.13M | 9.57M | -1.24M | — |
| Financing Cash Flow | 16.82M | 333.00K | 1.02M | 263.00K | 339.00K | 66.00K | 304.15M | -1.32M | — | — | 0 | — |
| Net Change in Cash | 13.06M | -49.12M | -199.27M | 130.68M | -20.73M | -28.15M | 149.95M | -42.93M | 49.83M | -7.14M | -10.04M | — |
| Free Cash Flow | -22.18M | -26.46M | -15.05M | 168.79M | -20.34M | -23.73M | -21.57M | -17.39M | -13.14M | -17.48M | -10.04M | — |
This table shows 12 quarterly periods of Septerna's cash flow statement, from Q2 2026 back to Q3 2023, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow SEPN's reporting calendar. What is a cash flow statement?